Kimberly-Clark’s revenue of $5.1 billion in Q3 was up 2% y-o-y. On an organic basis, sales were up 5%, driven by 6% pricing growth and product mix, partly offset by a 1% decline in volume.

GO currently has a forward P/E ratio of 17.47, while KMB has a forward P/E of 18.20. We also note that GO has a PEG ratio of 3.53. This popular metric is similar to the widely-known P/E ratio ...

Investors in Kimberly-Clark Corp. (Symbol: KMB) saw new options begin trading today, for the August 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the KMB ...

Kimberly-Clark Corporation (KMB), headquartered in Dallas, Texas, manufactures personal care and consumer tissue products in the U.S. and internationally. Valued at a market cap of $43.8 billion ...

Overall, the performance of CL and KMB stocks with respect to the index has been lackluster. Returns for CL stock were 2% in 2021, -5% in 2022, 4% in 2023, and 17% in 2024, while that for KMB ...

Looking at Kimberly-Clark’s peers in the household products segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Procter & Gamble delivered year-on ...

Kimberly-Clark Corporation's 2024 top-line declined due to currency headwinds, divestitures, and organic sales weakness, but margins improved thanks to cost-cutting. Management's Powering Care ...

Kimberly-Clark Corp. (NYSE: KMB) will invest over $2 billion in North America, launching its largest U.S. expansion in 30+ years. New facilities in Ohio and South Carolina aim to boost production ...

Kimberly-Clark is down 5.5% during the same time and is heading into earnings with an average analyst price target of $141.33 (compared to the current share price of $124.33).